date,title,source
Oct-22-18,Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer,GlobeNewswire
Oct-26-18,"Melinta Therapeutics to Report Third Quarter 2018 Financial Results on November 7, 2018",GlobeNewswire
